Tradestie Institutional Equity Comparison Engine
LABT vs ADVB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ADVB Overall Edge
ADVB Captures Institutional Edge (2โ0 Pillars ยท 7โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Advanced Biomed Inc. Common Stock (ADVB) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, LABT trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ADVB at N/M Forward P/E and -4883.8% operating margin (+0.0% YoY). In options structure, LABT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ADVB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
LABT N/M vs ADVB N/M Fwd P/E
Growth & Margin Winner
ADVB
Op Margin N/A vs -4883.8% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
ADVB
1Y -97.2% vs +299.2% ยท 52W Pos 1% vs 6%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
LABT
US Equity
LABT
Institutional Equity
$0.24
+15.03% 1D
Market Cap
N/A
1M Return
-49.97%
1Y Return
-97.17%
Forward P/E
N/M
Unified AI Score
47.5 / 100
HOLD
Tech 45.0
Fund 48.0
Flow 50.0
Mom 64.0
ADVB
NASDAQ
Advanced Biomed Inc. Common Stock
Services-Medical Laboratories
$1.65
-5.71% 1D
Market Cap
$2.9M
1M Return
-52.31%
1Y Return
+299.23%
Forward P/E
N/M
Unified AI Score
43.5 / 100
HOLD
Tech 33.0
Fund 48.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
LABT -97.17%
ADVB +299.23%
Spread: +22.67 pp (ADVB Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
LABT TTM Op. Margin: N/A
ADVB TTM Op. Margin: -4883.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LABT vs ADVB. Trailing 12-month operating profitability (LABT N/A vs ADVB -4883.8%) and valuation multiples (LABT N/M vs ADVB N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | LABT | ADVB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $2.9M | Larger Scale | ADVB |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | ADVB |
| Operating Margin (TTM) Profitability | N/A | -4883.8% | Higher Margin | ADVB |
| Net Profit Margin Profitability | N/A | 5231.3% | Higher Margin | ADVB |
| Return on Equity (ROE) Capital Efficiency | N/A | -79.5% | Higher ROE | ADVB |
| 52-Week Range Position Momentum | 1% ($0โ$10) | 6% ($0โ$24) | Stronger Trend | ADVB |
| Beta / 30D Volatility Risk Regime | -8.45ฮฒ ยท 672% Vol | 0.26ฮฒ ยท 216% Vol | Lower Realized Risk | ADVB |
| Unified Institutional Score Composite Signal | 47.5 / 100 (HOLD) | 43.5 / 100 (HOLD) | Higher Composite | LABT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full LABT vs ADVB Buy Guide
LABT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ADVB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither LABT nor ADVB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.